Clinical evaluation of the anti-inflammatory effect of chloramphenicol in combination with beclomethasone in patients with otitis externa and otitis media

Epidemiological studies indicate that chronic inflammation of the middle ear is one of the most common diseases in the field of otorhinolaryngology and accounts for up to 30% of all patients with diseases of the hearing organ. Among the many factors contributing to the occurrence of inflammatory ear diseases, upper respiratory tract infections, allergic reactions and/ or anatomical features play a special role. An analysis of the literature data showed that properly selected therapy, rational administration of antibacterial drugs, as well as prevention will significantly reduce the frequency of relapses of the disease and prevent the development of hearing loss. This material presents a clinical case, which shows that an important aspect of treatment is an individual approach to each patient, taking into account his age, general health and predisposition to infectious diseases. An integrated approach to the treatment and prevention of recurrent acute otitis media can significantly improve the patient’s quality of life, as well as reduce the burden of the disease on the health care system. The use of topical complex remedies for otitis media helps to reduce the chances of prescribing systemic antibiotics. The use is justified, among other things, in the moderate course of otitis media as part of complex treatment, since in the initial days of the disease such patients have a pronounced pain syndrome, which can be effectively stopped due to the synergistic action of an anesthetic (lidocaine 2%) and a glucocorticosteroid (beclomethasone). Patients note a significant improvement in their condition already in the first days of treatment, good tolerability, absence of unpleasant sensations or allergic reactions during use, while reducing the risks of potentiating the development of antibiotic resistance.

1. Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS ONE. 2012;7(4):e36226. https://doi.org/10.1371/journal.pone.0036226.

2. Boikova NE, Elkun GB. The use of Panclav 625 mg (amoxicillin/clavulanate) in the treatment of acute and chronic inflammatory diseases of the ENT organs. RMJ. 2007;(7):625–632. (In Russ.) Available at: https://www.rmj.ru/articles/klinicheskaya_farmakologiya/Ispolyzovanie_preparata_Panklav_625_mg_amoksicillinklavulanat_v_terapii_ostryh_i_hronicheskih_vospalitelynyh_zabolevaniy_LORorganov/.

3. Krukov AI, Kunel’skaya NL, Gurov AV, Elchueva ZG, Sokolov SS. The clinical picture and specific microbiological features of acute otitis media. Vestnik Oto-Rino-Laringologii. 2015;80(4):52–55. (In Russ.) https://doi.org/10.17116/otorino201580452-55.

4. Wetmore RF, Muntz HR, McGill TJI. Pediatric Otolaryngology Principles and Practice Pathways. 2nd ed. Thieme; 2012. 976 p.

5. Sotnikova LS, Rusetsky YuYu, Minasyan VS, Meytel IYu, Arutyunyan SK. Current views on the treatment and prevention of recurrent acute otitis media in children (review of clinical recommendations). Vestnik Oto-RinoLaringologii. 2022;87(1):46–51. (In Russ.) https://doi.org/10.17116/otorino20228701146.

6. Schilder AG, Chonmaitree T, Cripps AW, Rosenfeld RM, Casselbrant ML, Haggard MP, Venekamp RP. Otitis media. Nat Rev Dis Primers. 2016;2(1):16063. https://doi.org/10.1038/nrdp.2016.63.

7. Komarov MV, Fedotova AA, Bezrukova EV, Goncharov OI. Role of gastrointestinal tract acid-related diseases in formation of recurrent and irreversible chronic inflammatory phenomena in middle ear. Rossiiskaya Otorinolaringologiya. 2023;22(6):53–61. (In Russ.) https://doi.org/10.18692/1810-4800-2023-6-53-61.

8. Kokorina VE. Features of the clinical manifestation of otorhinolaryngological diseases caused by gastroesophageal reflux disease. Rossiiskaya Otorinolaringologiya. 2010;(3):84–88. (In Russ.) Available at: https://elibrary.ru/item.asp?id=16360005.

9. Svistushkin VM (ed.) Otolaryngology: clinical guidelines. Farmateka. 2018;(Suppl.):22–38. (In Russ.) Available at: Available at: https://new.pharmateca.ru/articles/Ostryi-srednii-otit-i-hronicheskii-gnoinyi-sredniiotit-u-vzroslyh-i-detei.html.

10. Pal’chun VT, Gurov AV, Mikhaleva LM, Gordienko MV. The modern approaches to the evaluation of the importance of chronic inflammation in the mucous membrane of the middle ear. Vestnik Oto-Rino-Laringologii. 2018;83(1):75–80. (In Russ.) https://doi.org/10.17116/otorino201883175-80.

11. Krivopalov AA, Yanov YuK, Shcherbuk AYu, Shcherbuk YuA, Rubin AN. Otogenic intracranial pyo-inflammatory complications. Grekov’s Bulletin of Surgery. 2017;176(6):101–105. (In Russ.) https://doi.org/10.24884/0042-4625-2017-176-6-101-105.

12. Kosiakov SIa, Nosulia EV, Perich B. Otogenic intracranial disorders: topical problems of diagnostics and treatment. Vestnik Oto-Rino-Laringologii. 2014;(1):64–69. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2014/1/030042-46682014118.

13. Isachenko VS, Dvoryanchikov VV, Ilyasov DM, Ognetov SY, Sotnikova KI. On the issue of effective engraftment of tissues in the plastic of the tympanic membrane. Meditsinskiy Sovet. 2022;(20):22–29. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-22-29.

14. Khaĭmanova IuV, Kosiakov SIa. The influence of chronic otitis media on the sensorineural component of hearing. Vestnik Oto-Rino-Laringologii. 2012;77(3):7–10. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/3/030042-4668201232

15. Dyachenko SV, Zhuravlev YaA, Krasnozhon TV. Dynamics of antimicrobial medications consumption in a multidisciplinary hospital (pharmacoepidemiological analysis). Far Eastern Medical Journal. 2017;(4):59–64. (In Russ.) Available at: http://eport.fesmu.ru/dmj/20174/2017415.aspx.

16. Kozlov RS, Muravyev AA, Shcherbakov ME, Rodnikova VYu, Romanenko VV, Safyanov KN. Study to assess incidence of acute otitis media in children under 5 years of age in Russia (PAPIRUS-AOM). Klinicheskaia Mikrobiologiia i Antimikrobnaia Khimioterapiia. 2017;19(2):116–120. (In Russ.) Available at: https://cmac-journal.ru/publication/2017/2/cmac-2017-t19-n2-p116.

17. Tarabichi M, Najmi M. Site of eustachian tube obstruction in chronic ear disease. Laryngoscope. 2015;125(11):2572–2575. https://doi.org/10.1002/lary.25330.

18. Zavarzin BA, Anikin IA. Candibiotic in the treatment of acute otitis externa and secondary. Rossiiskaya Otorinolaringologiya. 2011;(2):146–149. (In Russ.) Available at: https://cyberleninka.ru/article/n/kandibiotik-vlechenii-ostryh-srednih-i-naruzhnyh-otitov.

19. Kosyakov SYa, Lopatin AS. Modern principles of treatment of acute, prolonged and recurrent acute otitis media. RMJ. 2002;(20):903–909. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Sovremennye_principy_lecheniya_ostrogo_srednego_zatyanuvshegosya_i_recidiviruyuschego_ostrogo_srednego_otita/.

20. Kunelskaya VYa, Shadrin GB, Rasskazova TV, Kalinina IB. Otitis media. The role of bacterial and fungal infection. Meditsinskiy Sovet. 2013;(7):11–15. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-11-17.

21. Radzig EYu. The role of systemic and local drugs in the treatment of various forms of otitis media in children and adolescents. RMJ. 2013;(2):80–83. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Roly_sistemnyh_i_mestnyh_preparatov_v_lechenii_razlichnyh_form_otita_u_detey_i_podrostkov.